Yuki Gosei Kogyo Co., Ltd. (JP:4531)
:4531
Want to see JP:4531 full AI Analyst Report?
Top Page
Yuki Gosei Kogyo Co., Ltd.
(4531)
Select Model
Select Model
Rating:65Neutral
Price Target:
¥409.00
▲(29.02% Upside)
Action:Reiterated
Date:06/24/26
The score is mainly held back by financial performance: despite a stable capital structure, 2026 profitability declined sharply and cash flows have been volatile, even with the latest-year free cash flow rebound. Technicals are a supportive offset with bullish short-term trend signals. Valuation is moderate but looks somewhat stretched (P/E ~26) relative to the recent earnings weakness, tempered by a ~2.6% dividend yield.
Positive Factors
Balance-sheet strength
A persistent equity base with moderate leverage provides structural financial stability and borrowing capacity. This supports capital spending, dividends and cushions cyclicality, giving the company durable financial flexibility over the next several months despite earnings swings.
Negative Factors
Earnings step-down
A sharp decline in net income materially reduces operating cushion and signals margin pressure or higher costs. That magnitude of earnings volatility impairs planning, limits reinvestment capacity, and increases sensitivity to demand or input-cost shocks over the medium term.
Read all positive and negative factors
Positive Factors
Negative Factors
Balance-sheet strength
A persistent equity base with moderate leverage provides structural financial stability and borrowing capacity. This supports capital spending, dividends and cushions cyclicality, giving the company durable financial flexibility over the next several months despite earnings swings.
Read all positive factors
Yuki Gosei Kogyo Co., Ltd. (4531) vs. iShares MSCI Japan ETF (EWJ)
Market Cap
¥8.97B
Dividend Yield2.97%
Average Volume (3M)39.67K
Price to Earnings (P/E)26.2
Beta (1Y)1.13
Revenue Growth2.12%
EPS Growth-64.98%
CountryJP
Employees290
SectorBasic Materials
Sector Strength58
IndustryChemicals
Share Statistics
EPS (TTM)N/A
Shares Outstanding21,974,000
10 Day Avg. Volume32,460
30 Day Avg. Volume39,673
Financial Highlights & Ratios
PEG Ratio-0.41
Price to Book (P/B)0.62
Price to Sales (P/S)0.55
P/FCF Ratio4.89
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Yuki Gosei Kogyo Co., Ltd. Business Overview & Revenue Model
Company Description
Yuki Gosei Kogyo Co., Ltd. is a Japanese enterprise that globally researches, develops, produces, and markets sophisticated fine chemical products. Their diverse portfolio encompasses food-grade additives, pharmaceutical components, and chemicals ...
Yuki Gosei Kogyo Co., Ltd. Financial Statement Overview
Summary
Income Statement
61
Positive
Balance Sheet
68
Positive
Cash Flow
54
Neutral
| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 15.86B | 15.45B | 15.13B | 12.93B | 12.84B | 12.36B |
| Gross Profit | 3.19B | 2.55B | 3.23B | 3.26B | 3.05B | 2.36B |
| EBITDA | 1.93B | 1.62B | 2.23B | 1.93B | 1.56B | 1.18B |
| Net Income | 708.00M | 313.00M | 896.00M | 776.00M | 556.00M | 248.00M |
Balance Sheet | ||||||
| Total Assets | 27.35B | 25.73B | 27.29B | 24.75B | 22.35B | 21.38B |
| Cash, Cash Equivalents and Short-Term Investments | 1.05B | 885.00M | 973.00M | 588.00M | 1.14B | 1.86B |
| Total Debt | 9.06B | 6.71B | 8.51B | 6.87B | 5.58B | 5.54B |
| Total Liabilities | 14.31B | 12.24B | 14.18B | 12.31B | 10.87B | 10.38B |
| Stockholders Equity | 13.03B | 13.49B | 13.11B | 12.43B | 11.48B | 11.00B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 1.72B | -1.20B | -1.37B | -490.00M | 1.40B |
| Operating Cash Flow | 0.00 | 2.84B | 2.14B | 388.00M | 668.00M | 1.79B |
| Investing Cash Flow | 0.00 | -1.01B | -3.25B | -1.89B | -1.24B | -442.00M |
| Financing Cash Flow | 0.00 | -1.92B | 1.50B | 948.00M | -158.00M | -772.00M |
Yuki Gosei Kogyo Co., Ltd. Technical Analysis
Positive
317.00
Price Trends
357.58
Positive
392.12
Positive
342.84
Positive
Market Momentum
4.91
Negative
65.94
Neutral
74.43
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:4531, the sentiment is Positive. The current price of 317 is below the 20-day moving average (MA) of 353.90, below the 50-day MA of 357.58, and below the 200-day MA of 342.84, indicating a bullish trend. The MACD of 4.91 indicates Negative momentum. The RSI at 65.94 is Neutral, neither overbought nor oversold. The STOCH value of 74.43 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:4531.
Yuki Gosei Kogyo Co., Ltd. Peers Comparison
UnderperformOutperform
Sector (61)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | ¥130.17B | 48.94 | ― | 0.67% | 8.51% | -17.90% | |
73 Outperform | ¥8.48B | 2.61 | ― | 1.96% | 0.78% | 171.25% | |
70 Outperform | ¥193.74B | 10.46 | ― | 4.09% | -2.00% | 23.48% | |
65 Neutral | ¥8.97B | 26.19 | ― | 2.97% | 2.12% | -64.98% | |
63 Neutral | ¥15.07B | 11.60 | ― | 3.89% | -0.65% | -0.09% | |
63 Neutral | ¥17.69B | 21.21 | ― | 1.81% | 4.46% | -3.54% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% |
* Basic Materials Sector Average
JP:4531
Yuki Gosei Kogyo Co., Ltd.
380.00
121.54
47.03%
JP:4040
NANKAI CHEMICAL COMPANY LIMITED
3,580.00
559.07
18.51%
JP:4041
Nippon Soda Co., Ltd.
3,525.00
680.45
23.92%
JP:4093
Toho Acetylene Co., Ltd.
429.00
88.75
26.08%
JP:4366
Daito Chemix Corporation
521.00
292.74
128.25%
JP:4970
Toyo Gosei Co., Ltd.
16,600.00
12,162.61
274.09%
Yuki Gosei Kogyo Co., Ltd. Corporate Events
Yuki Gosei Kogyo Profit Slides Despite Higher Sales, Keeps Dividend and Flags Geopolitical Uncertainty
May 15, 2026
Yuki Gosei Kogyo reported a 2.1% rise in net sales to ¥15,448 million for the fiscal year ended March 31, 2026, but operating income plunged 68.4% and net income fell 65.1%, squeezing profitability metrics such as return on equity and operati...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.